# Nextech IV Oncology S.C.S. SICAV-SIF — Form D

Nextech IV Oncology S.C.S. SICAV-SIF of MUNSBACH, N4, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2014-12-11. The offering totals $150.0M, of which $40.1M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2014-12-11
- Form: D
- Accession: 0001627788-14-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $40.1M
- Remaining: $109.9M
- Investors: 20
- Date of first sale: 2014-09-26
- Security types: fund interests
- SEC file number: 021-229933

## Issuer

- Name: Nextech IV Oncology S.C.S. SICAV-SIF
- CIK: 0001627788
- Entity type: Limited Partnership
- Jurisdiction: LUXEMBOURG
- Incorporated: 2014
- Address: 1C, RUE GABRIEL LIPPMANN, MUNSBACH, N4, L-5365
- Phone: 352-451314-0

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| CHRISTOPH KRAIKER | Executive Officer | MUNSBACH, N4 |
| MARC KRIEGSMANN | Executive Officer | MUNSBACH, N4 |
| THOMAS LIPS | Executive Officer | ZURICH, V8 |
| n/a NEXTECH IV GP S.A.R.L. | Executive Officer | MUNSBACH, N4 |
| N/A NEXTECH INVEST AG | Promoter | LUXEMBOURG-FINDEL, N4 |

## More

- [CIK 1627788 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1627788&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001627788-14-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.